Manufacturer: Lilly, France, for Eli Lilly and Company, Indianapolis, IN Indication: Stimulation of new bone formation in patients with osteoporosis Drug Class: Teriparatide is a recombinant human parathyroid hormone (PTH), which is the primary regulator of calcium and phosphate metabolism in bones. It has an identical sequence to the 34N-terminal amino acids (the biologically active [...]
Continue reading " Pharmaceutical-Approval Update: Teriparatide (rDNA Origin) Injection (Forteo®) "
Manufacturer: Eli Lilly and Company, Indianapolis, IN Indication: Attention-deficit hyperactivity disorder (ADHD) Drug Class: Atomoxetine is classified as a selective norepinephrine reuptake inhibitor. Uniqueness of Drug: The precise mechanism by which atomoxetine produces its therapeutic effects in ADHD is unknown, but it is thought to be related to selective inhibition of the presynaptic norepinephrine transporter. [...]
Continue reading " Pharmaceutical-Approval Update: Atomoxetine Hydrochloride (Strattera™) "
Ezetimibe (Zetia drug) Manufacturer: Schering Corporation, Kenilworth NJ, for Merck/Schering-Plough Pharmaceuticals, North Wales, PA (joint venture) Indications: Primary hypercholesterolemia. Eze-timibe can be prescribed in several situations:
